IRB Authority and Institutional Commitment
(Procedure) Institutional Oversight of Mayo Clinic's Federalwide Assurance
(Procedure) Activities Subject to IRB Jurisdiction
(Procedure) Knowledge of Local Research Context
New (Procedure) Mayo Clinic IRBs Serving as the IRB of Record for a Relying Organization (Procedure) External IRB as IRB of Record Procedure
New (Procedure) Mayo Clinic IRBs Serving as the IRB of Record for a Relying Organization
(Procedure) External IRB as IRB of Record Procedure
IRB Compliance
(Procedure) Directed On-Site Review (Procedure) Internal Compliance Review Internal Compliance Review of Allegations of Suspected or Actual Noncompliance (Procedure) Routine On Site Quality Review (Procedure) Review of Allegations of Noncompliance by an IRB Committee
(Procedure) Directed On-Site Review
(Procedure) Internal Compliance Review Internal Compliance Review of Allegations of Suspected or Actual Noncompliance
(Procedure) Routine On Site Quality Review
(Procedure) Review of Allegations of Noncompliance by an IRB Committee
(Procedure) Administrative Hold Activation by the Principal Investigator (Procedure) Suspension for Cause and Termination for Cause on a Study
(Procedure) Administrative Hold Activation by the Principal Investigator
(Procedure) Suspension for Cause and Termination for Cause on a Study
(Procedure) Reporting to the Appropriate Institutional Officials and Department or Agency Head(s)
IRB Review Procedures
(Procedure) Institutional Review Board Member Review Responsibilities (Procedure) IRB Member Expectations, Roles, Recruitment and Evaluation Program
(Procedure) Institutional Review Board Member Review Responsibilities
(Procedure) IRB Member Expectations, Roles, Recruitment and Evaluation Program
(Procedure) IRB Committee Determinations/Motions – Full Committee Procedure
(Procedure) IRB Review of Human Subjects Research – Exempt
(Procedure) IRB Review of Human Subjects Research – Expedited
(Procedure) Management of IRB Member and Consultant Conflicts of Interest (Procedure) Conduct of IRB Meetings
(Procedure) Management of IRB Member and Consultant Conflicts of Interest
(Procedure) Conduct of IRB Meetings
(Procedure) IRB Approval of Research
(Procedure) Continuing Review (Procedure) Expired IRB Approval (Procedure) Final Report
(Procedure) Continuing Review
(Procedure) Expired IRB Approval
(Procedure) Final Report
(Procedure) Reporting Unanticipated Problems Involving Risks to Subjects or Others
(Procedure) Scientific Review of Research Involving Human Subjects
Informed Consent Process
Informed Consent Policies
(Guidance) Selecting a Legally Authorized Representative
Informed Consent Procedures Planning and the Informed Consent Process Recruitment and the Informed Consent Process Enrollment and the Informed Consent Process Documentation and the Informed Consent Process Study Participation and the Informed Consent Process Vulnerable Populations Research with Children and the Assent Process Obtaining and Documenting Informed Consent of Subjects who do not Speak English Special Considerations Requesting a Waiver of Written Informed Consent Waiving the Documentation of Informed Consent Re-consenting Study Subjects Responsibilities Summary of Investigator Responsibilities Summary of IRB Members Responsibilities Tools Quick Reference Guide – Informed Consent Process: Planning Through Study Closure Consent, Assent, and HIPAA Authorization Forms – Guidance for Revisions IRB Consent Form Template Oral Consent Script Telephone Script Contact Letter Template Assent Form Template IRB Handbook
Informed Consent Procedures
Vulnerable Populations
Special Considerations
Responsibilities
Tools
(Procedure) IRB Committee Membership
(Procedure) Special Categories of Research: Pregnant Women, Human Fetuses, and Neonates
(Procedure) Special Categories of Research: Children
(Procedure) Special Categories of Research: Other Participants Who May Be Vulnerable to Coercion or Undue Influence
Investigational Drugs, Biologics, and Devices
(Process) Emergency Use of an Investigational Drug, Agent, Biologic or Device
(Procedure) Emergency Use of an Investigational Drug, Agent or Biologic (Procedure) Investigational New Drug (IND) Use in a Clinical Investigation (Procedure) Investigational New Drug (IND) or Investigational Device Exemption (IDE) Applications; Reporting Requirements for Sponsor-Investigators
(Procedure) Emergency Use of an Investigational Drug, Agent or Biologic
(Procedure) Investigational New Drug (IND) Use in a Clinical Investigation
(Procedure) Investigational New Drug (IND) or Investigational Device Exemption (IDE) Applications; Reporting Requirements for Sponsor-Investigators
(Procedure) Emergency Use of an Investigational Device (Procedure) Investigational Device Exemptions (IDE) (Procedure) Control of Investigational Devices in Clinical Research (Procedure) Investigational New Drug (IND) or Investigational Device Exemption (IDE) Applications; Reporting Requirements for Sponsor-Investigators
(Procedure) Emergency Use of an Investigational Device
(Procedure) Investigational Device Exemptions (IDE)
(Procedure) Control of Investigational Devices in Clinical Research
(Procedure) Humanitarian Use Devices (HUD)
LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE
Use of this site signifies your agreement to the terms of use. © 2012 Mayo Foundation for Medical Education and Research. All rights reserved.